15 Feb 2020
How should aortic stenosis be treated in the modern era and what is the role of the heart team?
Sponsored by Edwards Lifesciences
Chairpersons:
K. Hayashida, B. Prendergast
Summary
Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.
Learning Objectives
- To share the current status of aortic stenosis treatment all over the world
- To discuss patient and treatment selection by the Heart Team
- How optimizing the patient pathway will facilitate the increasing demand for TAVR
